Domainex Ltd announces today that it has purchased and fully commissioned a Monolith NT.Automated instrument from NanoTemper Technologies Ltd. As the first UK contract research organisation to invest in the instrument, Domainex is in a unique position to offer its partners and clients improved fragment-based drug discovery (FBDD) services in their quest for new hit molecules.
December 2016
Thu, 15/12/2016 - 11:00
Thu, 15/12/2016 - 10:44
Auckland, New Zealand, 14th December 2016 / Sciad Newswire / A whitepaper released today by bioinformatics technology company
Tue, 13/12/2016 - 14:00
SynbiCITE and Rainbow Seed Fund today announce new sponsors and prizes for the Bio-start competition, designed to commercialise the engineering of biology. The addition of new sponsors increases the number of prizes available to competitors including the free use of laboratory space around the UK.
Mon, 12/12/2016 - 12:00
Newark, CA, USA, 12th December 2016 / Sciad Newswire / Founded in 2003 to marry computational design and gene synthesis, DNA2.0 was a pioneer in the application o
Wed, 07/12/2016 - 07:30
Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to expand the research collaboration with Adverum Biotechnologies that began in December 2015.
Mon, 05/12/2016 - 07:30
Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a collaboration with Sartorius Stedim Cellca (Cellca) to evaluate and test its customised synthetic promoters with Sartorius’ proprietary mammalian production cell platform. The goal of the programme is to reduce timelines and increase yields in the development of stable cell lines for the production of biopharmaceuticals.